Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy (REBIRTH) for Peripartum Cardiomyopathy

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Peripartum Cardiomyopathy
  • Age: Between 18 Year(s) - 99 Year(s)
  • Gender: Female
  • Other Inclusion Criteria:
    1. Current diagnosis of peripartum cardiomyopathy (PPCM)
    2. Post-delivery and within the first 5 months post-partum.
    3. Age = 18.

You may not be eligible for this study if the following are true:

    1. Previous diagnosis of cardiomyopathy, valvular disease or complex congenital heart disease (with the exception of women with a history of peripartum cardiomyopathy with complete recovery and a documented left ventricular ejection fraction (LVEF) > 0.55 prior to or in early pregnancy)
    2. Refractory hypertension (Systolic >160 or Diastolic > 95)
    3. Evidence of coronary artery disease (CAD)
    4. Previous cardiac transplant
    5. Current on durable Left ventricular assist device (LVAD) support
    6. Currently requiring extracorporeal membrane oxygenation (ECMO) support
    7. Current history of alcohol or drug abuse
    8. Chemotherapy or chest radiation within 5 years of enrollment
    9. Evidence of ongoing bacterial septicemia
    10. Medical, social or psychiatric condition which limit the ability to comply with follow-up



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.